Sign In

Andy Mychkovsky

Healthcare Strategy Consultant - Creator of healthcarepizza.com - 20K+ LinkedIn Followers

Professional Background

Andy Mychkovsky is a dedicated healthcare strategy leader passionate about leveraging digital health to improve patient outcomes. He currently holds a pivotal role at Evolent Health, a prominent technology-enabled services company operating across various sectors including Medicaid, Medicare, Commercial, and Self-Funded patients. His expertise spans strategy, operations, business development, and policy analysis, positioning him as a formidable figure in the healthcare landscape. At Evolent Health, Andy is instrumental in spearheading initiatives aimed at enhancing the effectiveness of healthcare delivery systems, ensuring that patient care is both efficient and accessible.

In addition to his full-time role, Andy also channels his insights and expertise into the healthcare startup ecosystem through his blog, Healthcare Pizza. As the founder and lead writer, he curates content that offers valuable perspectives on the latest trends and innovations in digital health. The blog serves as a platform for discussing various 'slices' of insights in healthcare that resonate with both professionals and the general public.

Prior to his current position at Evolent Health, Andy’s career has been marked by a series of impactful roles in strategy and business development within reputable organizations such as GoHealth Urgent Care and Cricket Health. These experiences have honed his capabilities in making strategic decisions that drive organizational growth and enhance patient care delivery.

Education and Achievements

Andy Mychkovsky's academic journey has laid a solid foundation for his career in healthcare. He began his studies at Petoskey High School, where he laid the groundwork for his interest in health sciences. He earned a Bachelor of Science (B.S.) in Health Science with a minor in Political Science from Grand Valley State University, which equipped him with a robust understanding of the healthcare sector coupled with a grasp of critical policy issues.

He then advanced his education with a Master of Health Services Administration (M.H.S.A.) in Health Management and Policy from the University of Michigan. This advanced degree has been pivotal in framing his approach to healthcare strategy and policy analysis, preparing him for leadership roles where he could effect meaningful change.

Throughout his career, Andy has not only developed a rich skill set but has also actively contributed to various organizations. His former role on the Board of Directors at NAMI Northern Virginia highlights his dedication to mental health advocacy. His work at CareFirst BlueCross BlueShield as part of the MBA CEO Graduate Development Program further illustrates his commitment to bridging the gap between business acumen and healthcare services.

Achievements

Andy Mychkovsky has made significant strides in the healthcare industry by embracing both innovation and collaboration. His substantial contributions to the field of digital health are reflected in the various leadership roles he has undertaken, including his position as Director of Strategy and Business Development at Evolent Health, where he has facilitated numerous initiatives aimed at enhancing healthcare delivery.

His consultative background as an Independent Consultant has also allowed him to provide strategic advisory services to various healthcare startups, thereby reinforcing his role in fostering innovation in the industry. Andy's journey has been characterized by a proactive approach to improving health systems, and he continues to play a vital role in shaping the future of healthcare delivery.

Conclusion

Andy Mychkovsky's rich educational background and extensive work experience highlight his dedication to improving the healthcare landscape through strategic innovation. His contributions to digital health, patient outcome improvement, and organizational growth position him as a leader in the industry. With an open invitation for connections, Andy welcomes discussions with fellow professionals and those looking to explore the intersection of technology and healthcare delivery.

Highlights

May 28 · linkedin

I’m worried about the state of venture capital and direct-to-consumer (DTC) healthcare startups.

Hims & Hers is the poster child for DTC healthcare at $1.2B proj 2024 revenue and a $3.6B valuation. By most accounts, they have been an outlier success for DTC since bottoming out in May 2022.

So why is this bad news for DTC healthcare?

Because the market leader (Hims) trades at a 3x forward revenue multiple. And the category leader typically gets a higher valuation multiple than smaller startups.

We see this phenomenon in private equity. They “roll up” smaller companies within the same category at a lower multiples just to create one larger platform that trades at higher multiples.

Now back to DTC healthcare startups. If Hims commands a 3x revenue multiple, it’s not unrealistic that smaller, unprofitable startups may be valued 1-2x revenue at exit.

At 2x revenue, a startup must generate $500M to produce a $1B exit in today’s market (depending on growth and profitability). Series A/B venture capitalists must see a pathway to $1B outcomes.

And if the growth-stage investors with billions under management are less interested in DTC healthcare, the future funding rounds necessary for fueling growth are not guaranteed. Juxtapose this against 2017-2022 where DTC could raise Series B-E funding.

Let’s take a DTC startup doing $25M after 3-4 years of operations and has already raised a Series A. By most accounts, it would be a phenomenal accomplishment. But today, investors will question the chances of that same company scaling from $25M to $500M revenue in the next 3-4 years with unknown future funding sources from Series B and beyond.

You're stuck in VC-funding purgatory.

Some of these companies will shut down. Some may sell for 1-3x revenue. And some may try to transition to profitable, cash-flowing businesses. All of which are certainly not the venture-backed goal the founders, investors, and employees often had in mind when first taking capital.

I say this all with friends working at or starting DTC healthcare companies, I feel bad for them. I also feel bad for the patients who enjoy those products or services.

To caveat (b/c I know people will object), there will be other DTC brands that exit for $1B+ (i.e., Ro). However, they were forged and scaled during a different time period where seemingly endless venture capital was available for DTC healthcare. Now we're in a different time with no end in sight.

Thoughts?

May 14 · linkedin

Someone broke down the estimated costs of a $15 Sweetgreen salad. We need these for digital health.

Especially for tech enabled cos, the greatest cost is labor. Much of the "value created" is in curation and matching, which means the gross margins are reliant on labor arbitrage. Pay someone $X, but get paid $X+Y% per visit.

The challenge with healthcare is that you often have to pick one of two business models:

  1. specialized, low volume, high cost, low gross margin %
  2. generalized, high volume, low cost, high gross margin %

I'd argue founders should focus on gross dollars over the lifetime of the customer (like Jeff Bezos said) instead of gross margin %'s, but we'll leave that for another time.

The challenge is that many tech enabled digital health cos have high cost of goods sold (labor) and moderately high product, design, and engineering budgets. We must build differentiated solutions for patients, clinicians, and clients to be out incumbents, however, we'll realizing that companies are ultimately valued on the discounted value of future cash flows.

And I'm not sure the math pencils out for everyone unfortunately.

But I'm just a guy on the internet, would love to hear the thoughts from those smarter than I (you!). Comment below.


p.s. I have no idea the accuracy of the graphic and not an investor in Sweetgreen. Cheers.

Credit: David Crowther

Someone broke down the estimated costs of a $15 Sweetgreen salad. We need these for digital health.

Related Questions

How did Andy Mychkovsky develop his expertise in healthcare strategy and digital health?
What motivated Andy Mychkovsky to create Healthcare Pizza, and what insights can readers gain from it?
In what ways has Andy's background in political science influenced his approach to health management and policy?
What strategic initiatives has Andy implemented at Evolent Health to enhance patient care services?
How does Andy Mychkovsky stay updated with the latest trends and innovations in healthcare?
Andy Mychkovsky
Add to my network

Location

Raleigh-Durham-Chapel Hill Area